Hemp Seed Oil For Dogs: Should You Use It?

This post was originally published on this site

Bergamaschi M, Costa Queiroz RH, Nisihara Chagas MH, de Oliveira D, De Martinis BS, Kapczinski F, Quevedo J, Roesler R, Schröder N, Nardi A, Martín-Santos R, Cecílio Hallak JE, Zuardi AW, Cripp JA. Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia PatientsNeuropsychopharmacology. May 2011. 36(6): 1219–1226. Published online 9, Feb 2011. doi: 10.1038/npp.2011.6.

Crippa JA, Derenusson GN, Ferrari TB, Wichert-Ana L, Fábio L, Duran S, Martin-Santos R, Simões MV, Bhattacharyya S, Fusar-Poli P, Atakan Z, Filho AS, Freitas-Ferrari MC, McGuire PK, Zuardi AW, Busatto GF, Cecílio Hallak JE. Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary reportJ Psychopharmacol. Jan 2011.25(1):121-30. 

de Mello Schier AR, de Oliveira Ribeiro NP, de Oliveira e Silva AC, Cecílio Hallak JE, Crippa JA. Nardi AE, Zuardi AW. Cannabidiol, a cannabis sativa constituent, as an anxiolytic drugBrazilian Journal of Psychiatry. vol.34 supl.1 São Paulo June 2012.

Lukhele ST, Motadi LR. Cannabidiol rather than Cannabis sativa extracts inhibit cell growth and induce apoptosis in cervical cancer cellsBMC Complement Altern Med. 2016. 

McKallip RJ, Jia W, Schlomer J, Warren J, Nagarkatti PS, Nagarkatti M. Cannabidiol-Induced Apoptosis in Human Leukemia Cells: A Novel Role of Cannabidiol in the Regulation of p22phox and Nox4 ExpressionMolecular Pharmacology. September 2006, 70 (3) 897-908.

Haustein M, Ramer R, Linnebacher M, Manda K, Burkhard Hinz B. Cannabinoids increase lung cancer cell lysis by lymphokine-activated killer cells via upregulation of ICAM-1Biochem Pharmacol. 15, Nov 2014. 92(2):312-25.

Fraguas-Sánchez AI, Fernández-Carballido A, Torres-Suárez AI. Phyto-, endo- and synthetic cannabinoids: promising chemotherapeutic agents in the treatment of breast and prostate carcinomasExpert Opinion on Investigational Drugs. Volume 25, 2016 – Issue 11. 16 Sep 2016, Published online: 28 Sep 2016.

Devinsky O, Sullivan J, Friedman D, Thiele E, Marsh E, Laux L, Hedlund J, Tilton N, Bluvstein J, Cilio M. Efficacy and safety of epidiolex (cannabidiol) in children and young adults with treatment-resistant epilepsy: initial data from an extended access program. American Epilepsy Society. 2014.

Porter BE, Jacobson C. Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsyEpilepsy Behavior. Dec 2013. 29(3): 574–577.

Formukong L, Evans AT, Evans FJ. Analgesic and antiinflammatory activity of constituents of cannabis sativaPubMed.gov. Aug 1988. 12(4):361-71.

Xiong W, Cui T, Cheng K, Yang F, Chen SR, Willenbring D, Guan Y, Pan HL, Ren K, Xu Y, Zhang L. Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptorsJournal of Experimental Medicine. 4, June 2012. 209(6): 1121–1134.

Booz GW. Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stressPubMed.gov. 1, Sep 2011. 51(5):1054-61. doi: 10.1016/j.freeradbiomed.2011.01.007. Epub 14, Jan 2011.

De Filippis D, Esposito G, Cirillo C, Cipriano M, De Winter BY, Scuderi C, Sarnelli G, Cuomo R, Steardo L, De Man JG, Iuvone T. Cannabidiol reduces intestinal inflammation through the control of neuroimmune axisPubMed.gov. 2011. 6(12):e28159.

Li K, Feng J, Li Y, Yuece B, Lin X, Yu L, Li Y, Feng Y, Storr M. Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in micePubMed.gov. Jan 2013. 42(1):123-9. 

Currais A, Quehenberger O, Armando AM, Daugherty D, Maher P, Schubert D. Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoidsnpj Aging and Mechanisms of Disease. Volume 2, Article number: 16012. June 2016.

Izzo AA, Camilleri M. Cannabinoids in intestinal inflammation and cancerPubMed.gov. Aug 2009. 60(2):117-25. doi: 10.1016/j.phrs.2009.03.008. Epub 18, Mar 2009.

Capasso R, Borrelli F, Aviello G, Romano B, Scalisi C, Capasso F, Izzo AA. Cannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in miceBritish Journal of Pharmacology. July 2008. 154(5): 1001–1008. Published online 12, May 2008. 

Formukong EA, Evans AT, Evans FJ. Analgesic and antiinflammatory activity of constituents of Cannabis sativa LPubMed.gov. Aug 1988. 12(4):361-71. 

Kozela E, Juknat A, Kaushansky N, Rimmerman N, Ben-Nun A, Vogel Z. Cannabinoids decrease the th17 inflammatory autoimmune phenotypePubMed.gov. Dec 2013. 8(5):1265-76. 

Mechoulam R, Peters M, Murillo-Rodriguez E, O Hanus L. Cannabidiol–recent advancesPubMed.gov. Aug 2007. 4(8):1678-92. 

Hampson AJ, Grimaldi M, Axelrod J, Wink D. Cannabidiol and (−)Δ9-tetrahydrocannabinol are neuroprotective antioxidantsProceedings Of The National Academy Of Sciences Of The United States Of America. 7, Jul 1998. 95(14): 8268–8273. 

Turner B, Talbot K. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALSPubMed.gov. May 2008. 85(1):94-134. 

Iuvone T, Esposito G, Esposito R, Santamaria R, Di Rosa M, Izzo AA. Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cellsPubMed.gov. Apr 2004. 89(1):134-41. 

Esposito G, De Filippis D, Carnuccio R, Izzo AA, Iuvone T. The marijuana component cannabidiol inhibits beta-amyloid-induced tau protein hyperphosphorylation through Wnt/beta-catenin pathway rescue in PC12 cellsPubMed.gov. Mar 2006. 84(3):253-8. 

Rock EM, Bolognini D, Limebeer CM, Cascio MG, Anavi-Goffer S, Fletcher PJ, Mechoulam R, Pertwee RG, Parker LA. Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleusPubMed.gov. Apr 2012. 165(8):2620-34. 

Darmani NA, Janoyan JJ, Crim J, Ramirez J. Receptor mechanism and antiemetic activity of structurally diverse cannabinoids against radiation-induced emesis in the Least shrewEuropean Journal Of Pharmaceutical Medicine. 1, Jun 2007. 563(1-3): 187–196.

Walsh SK, Hepburn CY, Kane KA, Wainwright CL. Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusionBritish Journal Of Pharmacology. Jul. 2016. 160(5): 1234–1242.

Stanley CP, Hind WH, O’Sullivan SE. Is the cardiovascular system a therapeutic target for cannabidiol? British Journal Of Clinical Pharmacology. Feb 2013. 75(2): 313–322.
Published online 1, Jun 2012. 

Resstel L, Joca S, Moreira F, Corrêa F, Guimarães F. Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in ratsPubMed.gov. 25, Sep 2006. 172(2):294-8. 

Bergamaschi MM, Costa Queiroz RH, Zuardi AW, Crippa J. Safety and side effects of cannabidiol, a Cannabis sativa constituentPubMed.gov. 1, Sep 2011. 6(4):237-49. 

Leave a Comment

Your email address will not be published. Required fields are marked *